US Melanoma Market is fast growing and expected to reach US$3.2 billion by 2023

US Melanoma Market
Market Research Future has a half cooked research report on US melanoma market. The US Melanoma market is growing continuously and expected to grow at a CAGR of 8.3% from 2016 to 2023.

US Melanoma Market by Type (Superficial spreading, Nodular, Lentigo maglina, Acral Lentigious and others); by Gender (Male and Female); by Treatment (Immunotherapy, Biologic Therapy, Radiation Therapy, Chemotherapy, Surgery and Others); By Diagnosis (ABCDE, Ugly Duckling, Biopsy and Others), by End Users (Hospitals, Pharmaceutical Companies, Research Centers, Clinics, Laboratories) – Forecast till 2023

The US melanoma market has been evaluated as fast growing market and it is expected that the market will continue to grow similarly in the near future. Melanoma is a type of cancer that develops from pigment containing cells known as melanocytes. It is the most dangerous type of skin cancer. The tumor can be either malignant or benign. Types of melanoma are superficial spreading melanoma, nodular melanoma, lentigo maglina melanoma, acral lentigious melanoma, and others. About 98% of melanoma is localized in the US.

US melanoma market was about US$ 2.4 billion in 2015 and is expected to reach US$ 3.2 billion by 2023 at a CAGR of 8.3%.

Test the market data and market information presented through more than 25 market data tables and figures spread over 51 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “US Melanoma Market Research Report – Global Forecast to 2023.”

 Get a Sample report at https://www.marketresearchfuture.com/sample_request/2950 .

US Melanoma Market Players:

Some of the key players in this market are: Amgen, Inc., Bristol-Myers Squibb, Eisai Co. Ltd., F. Hoffmann-La Roche Ltd., Genentech Inc. Janssen Biotech, Inc., and Novartis International AG. Pfizer, Vical and Ziopharm.

Regional Analysis:

Melanoma market in the US is divided into sates comprising of Georgia, New Jersey, North Carolina, New York, Florida, Illinois, Ohio, Pennsylvania, Texas, Washington, California, Virginia and Rest of US. California accounts for the largest market for melanoma in US followed by Florida and Ohio.

In the US, California and Florida are key regions for Melanoma market. Large number of melanoma cases are found in this region.  New York is third largest market after Florida. In the US the incidence of melanoma is found to be increasing due to indoor tanning. Tanning devices are used in spas, salons, hotels and sporting facilities. Tanning devices emit UV radiations thus increasing the risk of cancer. Technological advancement in the field of treatment and diagnosis of melanoma in the US also drives this market. Government initiates to tackle this diseases are also important drivers for this market.

US melanoma market has been segmented on the basis of type (superficial, nodular, lentigo maglina, acral, polypoid, desmoplastic), by gender (male and female), by treatment (immunotherapy, biologic therapy, radiation therapy, chemotherapy, surgery and others), by diagnosis (ABCDE, ugly duckling, biopsy, and others) and by end users (hospitals, pharmaceutical companies, research centers, clinics, laboratories).

Melanoma is a type of cancer that develops from pigment containing cells known as melanocytes. It is the most dangerous type of skin cancer. Sometimes they develop from moles showing significant change in color, increase in size, itchiness, irregular edges, changein color or skin breakdown. Exposure to ultra violet light in people with low pigment levels. The tumor can be either malignant or benign. Types of melanoma are superficial spreading melanoma, nodular melanoma, lentigo maglina melanoma, acral lentigious melanoma and others. About 98% of melanoma is localized in the US. Skin cancer are most common cancers in the US. Treatment available for melanoma include biologic therapy, immune therapy, radiation therapy, chemotherapy and surgery. Ultra violet exposure is known as risk factor of melanoma. Superficial spreading melanoma is the type of melanoma affecting large number of people in the US. The disease is more common in men than women. 

 Get a discount at https://www.marketresearchfuture.com/check-discount/2950

The report for US melanoma market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Table Of Contents

1       Report Prologue    

2       Market Introduction    

      2.1    Introduction    

      2.2    Scope Of Study    

      2.3    Research Objective    

      2.4    Assumptions & Limitations    

            2.4.1    Assumptions    

            2.4.2    Limitations    

3       Research Methodology    

      3.1    Research Process    

      3.2    Primary Research    

      3.3    Secondary Research    

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/us-melanoma-market-2950